When to Start Anti-HIV Drugs in Patients With Opportunistic Infections
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of starting anti-HIV drugs in HIV
infected patients who are being treated for opportunistic infections (OIs). This study will
follow two patient groups: those who received anti-HIV drugs soon after being diagnosed with
an OI and patients with OIs who deferred beginning anti-HIV drugs until after recovering from
the OI.
Phase:
Phase 4
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)